HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
91.12%
Total 13F principal
$408,645,440
Principal change
+$626,000
Total reported market value
$378,634,000
Number of holders
34
Value change
+$3,608,363
Number of buys
18
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q2 2016

As of 30 Jun 2016, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 34 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $408,645,440 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT CO, OAKTREE CAPITAL MANAGEMENT LP, KINGDON CAPITAL MANAGEMENT, L.L.C., Linden Advisors LP, Allianz Asset Management AG, FMR LLC, TD ASSET MANAGEMENT INC, CNH PARTNERS LLC, ADVENT CAPITAL MANAGEMENT /DE/, and Polar Asset Management Partners Inc.. This page lists 34 institutional bondholders reporting positions for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.